Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02305, also known as long intergenic non-protein coding RNA 2305, is a human gene encoding a long intergenic non-coding RNA (lincRNA). LincRNAs are transcripts longer than 200 nucleotides that do not overlap protein-coding genes and have limited or no protein coding potential. They are involved in diverse regulatory processes, including modulation of gene expression at the transcriptional and post-transcriptional level, often by acting as molecular sponges for microRNAs or recruiting chromatin-modifying complexes. While aberrant expression of lincRNAs is implicated in cancer and other diseases, and some are being explored as therapeutic targets or biomarkers, there are currently no drugs, disease associations, or functional studies published specifically for LINC02305. LINC02305 is indexed in major gene databases (GeneCards, NCBI, Ensembl), but its biological and disease roles remain to be further elucidated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2305 (LINC02305).